The concrete change is medicinal
The most significant change since 2024 is Spain’s framework for standardised cannabis preparations under Royal Decree 903/2025, followed by a published 2026 National Formulary monograph. These instruments give specified medicinal preparations a pharmaceutical route involving specialists, hospital pharmacies and AEMPS oversight. They do not create a general recreational retail market. Understanding the 2026 position therefore starts with the new clinical system, then separates it from the rules governing public conduct and associations.
What the decree organises
The decree establishes a registry for standardised preparations and defines professional responsibilities. Hospital specialists prescribe within the framework, documenting the clinical justification when authorised and marketed industrial medicines cannot satisfactorily treat the individual patient. Hospital pharmacy services prepare and dispense the prescribed formulations and participate in follow-up. Treatment continuation is evaluated rather than assumed indefinitely. Reporting suspected adverse reactions forms part of the system, connecting individual care with pharmacovigilance.
The monograph is already published
The 2026 monograph concerns an oral THC/CBD solution. It specifies last-line treatment in refractory cases of multiple-sclerosis spasticity, severe epilepsy, chemotherapy-related nausea and vomiting, and chronic pain, when authorised industrial medicines do not satisfactorily treat the particular patient. This is an actual published pharmaceutical document, not merely a promise of future guidance. Publication establishes the technical framework; it does not establish that every hospital has identical stock or that every person with one of these conditions receives the preparation.
Public possession follows another law
Organic Law 4/2015 still treats illicit public possession or consumption as a serious administrative infringement, even without trafficking intent. Public places and collective transport are expressly included. The Criminal Code separately addresses trafficking and conduct promoting or facilitating unlawful consumption. A medicinal reform cannot be read as a repeal of those provisions. Different legal questions arise for a prescribed preparation within healthcare and for illicit possession in the street.
Associations retain an organisational framework
Organic Law 1/2002 provides the general rules for associations: statutes, democratic governance, membership records, accounts and members’ rights. Registration establishes an organisation under that framework; it is not the pharmaceutical authorisation created by the 2025 decree. Nor does it create a national adult-use retail licence. Spain in 2026 therefore has a more explicit route for certain medicinal preparations alongside longstanding criminal, administrative and association rules. The change is meaningful precisely because its professional roles and clinical scope are now defined.
Sources & further reading
General information, not individual legal or medical advice.